Cat. No. 5939
Chemical Name: N-[4-[(3-Chloro-4-fluorophenyl)amin
Biological ActivityHigh affinity and potent covalent EGFR kinase inhibitor (Ki = 0.14 nM). Inhibits autophosphorylation of WT and mutant EGFR in tumor cells (IC50 values are 5.8 and 6.6 nM, respectively).
Licensing InformationSold for research purposes under agreement from Pfizer Inc.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Schwartz et al (2014) Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance. Proc.Natl.Acad.Sci.U.S.A. 111 173. PMID: 24347635.
If you know of a relevant reference for PF 6274484 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses PF 6274484 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: PF 6274484, supplier, PF6274484, epidermal, growth, factor, receptors, EGFR, kinase, inhibitors, inhibits, potent, high, affinity, covalent, Tocris Bioscience, EGFR Inhibitor products
Find multiple products by catalog number
New Products in this Area
Potent and selective PDGFR inhibitorGSK 1363089
Potent inhibitor of MET, VEGFR2, Ron and AXL
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.